You are here
Search FHI 360
Search FHI 360
Apply Health filter
Research services (5)
Apply Research services filter
Training and technical assistance (1)
Apply Training and technical assistance filter
Apply Article filter
Remove HIV and AIDS filter
HIV and AIDS
Remove Key populations filter
Remove U.S. HIV programs filter
U.S. HIV programs
Clinical trials design and implementation (1)
Apply Clinical trials design and implementation filter
Family planning (2)
Apply Family planning filter
HIV prevention (12)
Apply HIV prevention filter
Maternal, newborn and child health (2)
Apply Maternal, newborn and child health filter
Reproductive and sexual health (2)
Apply Reproductive and sexual health filter
Reproductive health research (1)
Apply Reproductive health research filter
South Africa (1)
Apply South Africa filter
Apply Tanzania filter
Apply Thailand filter
Apply Zimbabwe filter
Remove News filter
Start a New Search
Search within these results
U.S. HIV programs
13 Results Found
FHI 360 commends PEPFAR Blueprint release
RESEARCH TRIANGLE PARK, NC — FHI 360 applauds today's release of the PEPFAR Blueprint: Creating an AIDS-free Generation. This document provides a roadmap for how the U.S. government will work with partners to help achieve an AIDS-free generation...
Advancing Partners and Community-Based Family Planning Grant awarded to JSI, FHI 360
RESEARCH TRIANGLE PARK, NC — FHI 360 has been named a technical partner in the Advancing Partners and Community-Based Family Planning Cooperative Agreement that the U.S. Agency for International Development has awarded to JSI Research and Training...
Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs
RESEARCH TRIANGLE PARK, NC — Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP...
FHI 360 senior scientist Lut Van Damme receives International Microbicide Conference Lifetime Achievement Award
RESEARCH TRIANGLE PARK, NC — In recognition of her many significant contributions to the field of HIV prevention, FHI 360 Senior Scientist Lut Van Damme, MD, PhD received a Lifetime Achievement Award this week at the 2012 International Microbicides...
'Science' names HIV prevention trial as breakthrough of the year
RESEARCH TRIANGLE PARK, NC — Today, Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a...
VOICE HIV prevention trial discontinues Tenofovir gel arm
RESEARCH TRIANGLE PARK, NC — The Microbicides Trials Network (MTN) announced today that it will discontinue testing tenofovir vaginal gel in the HIV prevention trial VOICE (Vaginal and Oral Interventions to Control the Epidemic). This decision came...
UNICEF and FHI 360 renew global memorandum of understanding
ARLINGTON, VA — UNICEF signed a Memorandum of Understanding (MOU) with FHI 360 to strengthen cooperation and support in improving the lives of children and their families through policy, advocacy, programs and research in global health and...
Pre-exposure prophylaxis trials demonstrate effectiveness in preventing HIV infection among heterosexuals
RESEARCH TRIANGLE PARK, NC — Results announced today by the two clinical trial teams, Partners PrEP and TDF2, provide the first evidence that HIV infection among heterosexuals can be prevented by taking an oral, once-daily tablet. Pre-exposure...
Anti-HIV gel leadership team acknowledged for outstanding achievement in world health
CHICAGO, IL — Today the CAPRISA 004 study leadership team is being awarded the inaugural Drug Information Association (DIA) President's Award for Outstanding Achievement in World Health. The award recognizes the team's significant contribution to...
Initiation of antiretroviral treatment protects uninfected sexual partners from HIV infection
Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by 96 percent through early initiation of oral antiretroviral therapy (ART), according to findings from a large-scale multinational clinical study...